Table 3.
Resource use
| Age < 75 (n = 1073) | Age ≥75 (n = 212) | p | |
|---|---|---|---|
| Cost of treatments in €, median (IQR) | |||
| Hospital costs | 29 971 (13 381 − 50 212) | 18 356 (9 740 − 37 102) | < 0.001 |
| Rehabilitation | 0 (0–6 543) | 0 (0–7 574) | 0.928 |
| Social Insurance Institution | 1 669 (579-6 686) | 714 (392-1 760) | < 0.001 |
| Cost of treatment of those with CPC 1–2 after 12 months in €, median (IQR) (57 %) | |||
| Hospital | 41 194 (27 031–63 709) | 34 888 (19 083 − 60 029) | 0.071 |
| Rehabilitation | 2113 (0–9 603) | 6073 (417 − 13 319) | 0.012 |
| Social Insurance Institution | 4 561 (1 173 − 15 043) | 2 049 (1 196-3 509) | < 0.001 |
| Total cost in €, median (IQR) | |||
| Everyone | 38 195 (16 505-71680) | 22 641 (12 488 − 47 006) | < 0.001 |
| Those with CPC 1–2 after 12 months (57) | 54 510 (36 148 − 86 461) | 39 482 (24 101 − 93 020) | 0.040 |
| Effective costa in € | |||
| Of those with CPC 1–2 after 12 months | 119 941 | 168 416 | - |
| Effective cost in € among those with CPC 1–2 after 12 months | |||
| OHCA | 90 499 | 133 134 | - |
| IHCA | 161 670 | 199 540 | - |
| ICUCA | 308 000 | 172 595 | - |
aEffective cost: The total healthcare-associated costs of all patients within their respective age group divided by the number of survivors with a favourable neurological outcome